These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3838330)

  • 1. Pharmacokinetics and biologic effects of calcitriol in normal humans.
    Levine BS; Singer FR; Bryce GF; Mallon JP; Miller ON; Coburn JW
    J Lab Clin Med; 1985 Feb; 105(2):239-46. PubMed ID: 3838330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between urinary calcium and calcium intake during calcitriol administration.
    Smothers RL; Levine BS; Singer FR; Bryce GF; Mallon JP; Miller ON; Coburn JW
    Kidney Int; 1986 Feb; 29(2):578-83. PubMed ID: 3754596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary calcium and serum 1,25-(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men.
    Maierhofer WJ; Lemann J; Gray RW; Cheung HS
    Kidney Int; 1984 Nov; 26(5):752-9. PubMed ID: 6549194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of magnesium on renal and intestinal calbindin-D.
    Hemmingsen C; Staun M; Olgaard K
    Miner Electrolyte Metab; 1994; 20(5):265-73. PubMed ID: 7700214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women.
    Packer E; Holloway L; Newhall K; Kanwar G; Butterfield G; Marcus R
    J Bone Miner Res; 1990 Aug; 5(8):877-84. PubMed ID: 2173358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.
    Winer KK; Yanovski JA; Cutler GB
    JAMA; 1996 Aug; 276(8):631-6. PubMed ID: 8773636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.
    Winer KK; Yanovski JA; Sarani B; Cutler GB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3480-6. PubMed ID: 9768650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calciuric response to 1,25-(OH)2D3 in early renal failure.
    Cremer B; Lübbers E; Klooker P; Schmidt-Gayk H; Ritz E
    Miner Electrolyte Metab; 1985; 11(3):182-5. PubMed ID: 3839286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
    Cosman F; Nieves J; Shen V; Lindsay R
    J Bone Miner Res; 1995 Apr; 10(4):594-600. PubMed ID: 7610930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 22-oxacalcitriol on serum calcitriol.
    Dusso AS; Negrea L; Finch J; Kamimura S; Lopez-Hilker S; Mori T; Nishii Y; Brown A; Slatopolsky E
    Endocrinology; 1992 Jun; 130(6):3129-34. PubMed ID: 1597134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hypomagnesemia caused by cisplatin: effect of calcitriol.
    Sutton RA; Walker VR; Halabe A; Swenerton K; Coppin CM
    J Lab Clin Med; 1991 Jan; 117(1):40-3. PubMed ID: 1987306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of congenital osteopetrosis with high-dose calcitriol.
    Key L; Carnes D; Cole S; Holtrop M; Bar-Shavit Z; Shapiro F; Arceci R; Steinberg J; Gundberg C; Kahn A
    N Engl J Med; 1984 Feb; 310(7):409-15. PubMed ID: 6546410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.
    Winer KK; Ko CW; Reynolds JC; Dowdy K; Keil M; Peterson D; Gerber LH; McGarvey C; Cutler GB
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4214-20. PubMed ID: 12970289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolism.
    Bell NH; Epstein S; Shary J; Greene V; Oexmann MJ; Shaw S
    J Bone Miner Res; 1988 Oct; 3(5):489-95. PubMed ID: 2848397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
    Banalagay E; Bernardini J; Holley J; Chen T; Piraino B
    Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of absorptive hypercalciuria in tuberculosis patients.
    Martinez ME; Gonzalez J; Sanchez-Cabezudo MJ; Peña JM; Vazquez JJ; Felsenfeld A
    Calcif Tissue Int; 1993 Dec; 53(6):384-7. PubMed ID: 8293351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans.
    Portale AA; Halloran BP; Murphy MM; Morris RC
    J Clin Invest; 1986 Jan; 77(1):7-12. PubMed ID: 3753709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response study.
    Body JJ; Dumon JC; Piccart M; Ford J
    J Bone Miner Res; 1995 Aug; 10(8):1191-6. PubMed ID: 8585422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.